Arcadia Biosciences Enters Material Definitive Agreement
Ticker: RKDA · Form: 8-K · Filed: May 2, 2025 · CIK: 1469443
| Field | Detail |
|---|---|
| Company | Arcadia Biosciences, Inc. (RKDA) |
| Form Type | 8-K |
| Filed Date | May 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, sec-filing
TL;DR
Arcadia Biosciences just signed a big deal, filing an 8-K on it.
AI Summary
Arcadia Biosciences, Inc. announced on April 30, 2025, that it entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in Dallas, Texas, filed this 8-K report on May 2, 2025, detailing this significant event.
Why It Matters
This filing indicates a significant business development for Arcadia Biosciences, potentially impacting its operations, financial standing, and future strategic direction.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can carry significant risks depending on the nature of the agreement, which is not fully detailed in this initial filing.
Key Numbers
- 001-37383 — SEC File Number (Identifies the company's filing with the SEC.)
- 81-0571538 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Arcadia Biosciences, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Dallas, Texas (location) — Principal Executive Offices
- April 30, 2025 (date) — Date of earliest event reported
- May 2, 2025 (date) — Filing Date
FAQ
What is the nature of the material definitive agreement entered into by Arcadia Biosciences, Inc. on April 30, 2025?
The filing states that Arcadia Biosciences, Inc. entered into a material definitive agreement on April 30, 2025, but the specific details of this agreement are not provided in this initial 8-K filing.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on May 2, 2025.
Where are Arcadia Biosciences, Inc.'s principal executive offices located?
Arcadia Biosciences, Inc.'s principal executive offices are located at 5950 Sherry Lane Suite 215, Dallas, Texas, 75225.
What is the company's state of incorporation?
Arcadia Biosciences, Inc. is incorporated in Delaware.
What is the SEC file number for Arcadia Biosciences, Inc.?
The SEC file number for Arcadia Biosciences, Inc. is 001-37383.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 2, 2025 regarding Arcadia Biosciences, Inc. (RKDA).